{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:05:35Z","timestamp":1792044335671,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI148260"],"award-info":[{"award-number":["R01AI148260"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Microbe"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.lanmic.2025.101337","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:55:51Z","timestamp":1778871351000},"page":"101337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Norovirus GII.4 serological repertoire in older adults after GII.4 ancestral variant vaccination: a post-hoc analysis of a randomised, double-blind, phase 2 trial"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9567-0522","authenticated-orcid":false,"given":"Lisa C","family":"Lindesmith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R","family":"Zweigart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D","family":"Brewer-Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesica","family":"Swanstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoska I","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L","family":"Mallory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha R","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily M","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3143-6515","authenticated-orcid":false,"given":"Rachel L","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Borkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6505-7281","authenticated-orcid":false,"given":"Michael E","family":"Abram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph S","family":"Baric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanmic.2025.101337_bib1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s12016-021-08905-x","article-title":"Immune memory in aging: a wide perspective covering microbiota, brain, metabolism, and epigenetics","volume":"63","author":"Bulut","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.lanmic.2025.101337_bib2","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.idc.2017.07.012","article-title":"Norovirus infection in older adults: epidemiology, risk factors, and opportunities for prevention and control","volume":"31","author":"Cardemil","year":"2017","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.lanmic.2025.101337_bib3","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciaa438","article-title":"Burden of norovirus in the United States, as estimated based on administrative data: updates for medically attended illness and mortality, 2001\u20132015","volume":"73","author":"Burke","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101337_bib4","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.3390\/v14122811","article-title":"Norovirus: an overview of virology and preventative measures","volume":"14","author":"Winder","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.lanmic.2025.101337_bib5","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.3390\/v13102033","article-title":"Serological humoral immunity following natural infection of children with high burden gastrointestinal viruses","volume":"13","author":"Zweigart","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.lanmic.2025.101337_bib6","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1473-3099(24)00691-1","article-title":"Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990\u20132021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021","volume":"25","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101337_bib7","doi-asserted-by":"crossref","first-page":"7097","DOI":"10.1016\/j.vaccine.2012.09.040","article-title":"The potential economic value of a human norovirus vaccine for the United States","volume":"30","author":"Bartsch","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.lanmic.2025.101337_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ads0556","article-title":"An oral norovirus vaccine tablet was safe and elicited mucosal immunity in older adults in a phase 1b clinical trial","volume":"17","author":"Flitter","year":"2025","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.lanmic.2025.101337_bib9","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.1016\/j.vaccine.2020.06.011","article-title":"A phase 2 study of the bivalent VLP norovirus vaccine candidate in older adults; impact of MPL adjuvant or a second dose","volume":"38","author":"Treanor","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.lanmic.2025.101337_bib10","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2015874118","article-title":"Antigenic cartography reveals complexities of genetic determinants that lead to antigenic differences among pandemic GII.4 noroviruses","volume":"118","author":"Kendra","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.lanmic.2025.101337_bib11","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1371\/journal.pmed.0050031","article-title":"Mechanisms of GII.4 norovirus persistence in human populations","volume":"5","author":"Lindesmith","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.lanmic.2025.101337_bib12","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S1473-3099(18)30059-8","article-title":"Molecular surveillance of norovirus, 2005\u201316: an epidemiological analysis of data collected from the NoroNet network","volume":"18","author":"van Beek","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101337_bib13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/cid\/ciab808","article-title":"Norovirus outbreaks in long-term care facilities in the United States, 2009\u20132018: a decade of surveillance","volume":"74","author":"Calderwood","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101337_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/civ747","article-title":"Epidemiologic, virologic, and host genetic factors of norovirus outbreaks in long-term care facilities","volume":"62","author":"Costantini","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101337_bib15","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nm860","article-title":"Human susceptibility and resistance to Norwalk virus infection","volume":"9","author":"Lindesmith","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.lanmic.2025.101337_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ads8214","article-title":"Broadly neutralizing antibodies targeting pandemic GII.4 variants or seven GII genotypes of human norovirus","volume":"17","author":"Park","year":"2025","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.lanmic.2025.101337_bib17","first-page":"739","article-title":"Comparison of microneutralization and histo-blood group antigen-blocking assays for functional norovirus antibody detection","volume":"221","author":"Atmar","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101337_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01861-22","article-title":"Immune imprinting drives human norovirus potential for global spread","volume":"13","author":"Lindesmith","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.lanmic.2025.101337_bib19","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.immuni.2019.05.007","article-title":"Sera antibody repertoire analyses reveal mechanisms of broad and pandemic strain neutralizing responses after human norovirus vaccination","volume":"50","author":"Lindesmith","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.lanmic.2025.101337_bib20","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1016\/j.vaccine.2012.03.050","article-title":"Immunogenicity and specificity of norovirus Consensus GII.4 virus-like particles in monovalent and bivalent vaccine formulations","volume":"30","author":"Parra","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.lanmic.2025.101337_bib21","article-title":"Emergent variant modeling of the serological repertoire to norovirus in young children","volume":"4","author":"Lindesmith","year":"2023","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.lanmic.2025.101337_bib26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3201\/eid3001.231003","article-title":"Emergence of novel norovirus GII.4 variant","volume":"30","author":"Chhabra","year":"2024","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.lanmic.2025.101337_bib23","author":"Maechler"},{"key":"10.1016\/j.lanmic.2025.101337_bib24","series-title":"Phenotypic Bayesian phylodynamics: hierarchical graph models, antigenic clustering and latent liabilities","author":"Cybis","year":"2014"},{"key":"10.1016\/j.lanmic.2025.101337_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001807","article-title":"Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trial","volume":"12","author":"Lindesmith","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.lanmic.2025.101337_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/ve\/veaa067","article-title":"Preadaptation of pandemic GII.4 noroviruses in unsampled virus reservoirs years before emergence","volume":"6","author":"Ruis","year":"2020","journal-title":"Virus Evol"},{"key":"10.1016\/j.lanmic.2025.101337_bib28","doi-asserted-by":"crossref","first-page":"7256","DOI":"10.1128\/JVI.00785-14","article-title":"4 norovirus virus-like-particle-based vaccines induce broadly blocking immune responses","volume":"88","author":"Debbink","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.lanmic.2025.101337_bib29","doi-asserted-by":"crossref","DOI":"10.1111\/irv.70076","article-title":"Rethinking optimal immunogens to face SARS-CoV-2 evolution through vaccination","volume":"19","author":"Blanco","year":"2025","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.lanmic.2025.101337_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114990","article-title":"Modulating the immunodominance hierarchy of immunoglobulin germline-encoded structural motifs targeting the influenza hemagglutinin stem","volume":"43","author":"Ataca","year":"2024","journal-title":"Cell Rep"}],"container-title":["The Lancet Microbe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666524725002654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666524725002654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:06:38Z","timestamp":1785884798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666524725002654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2666524725002654"],"URL":"https:\/\/doi.org\/10.1016\/j.lanmic.2025.101337","relation":{},"ISSN":["2666-5247"],"issn-type":[{"value":"2666-5247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Norovirus GII.4 serological repertoire in older adults after GII.4 ancestral variant vaccination: a post-hoc analysis of a randomised, double-blind, phase 2 trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Microbe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanmic.2025.101337","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101337"}}